Assessing Risk of Unintended Antigen Occurrence in Food: A Case Instance for Maize-Expressed LT-B

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Human and Ecological Risk Assessment: An International Journal

• Publication date

  2006-10-01

• Fields of study

  Agricultural and Food Sciences, Biology, Environmental Science

• Identifiers
  DOI 10.1080/10807030600826805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of an edible subunit vaccine in corn against enterotoxigenic strains of escherichia coli

  2007cited by this paper
• US launches probe into sales of unapproved transgenic corn

  2005cited by this paper
• Novel vaccination strategies.

  2004cited by this paper
• On risk and plant-based biopharmaceuticals.

  2004influential reference
• Plant‐Based Oral Vaccines

  2004cited by this paper
• A Quantitative Safety Assessment Model For Transgenic Protein Products Produced In Agricultural Crops

  2004cited by this paper
• Quantitative exposure assessment for confinement of maize biogenic systems.

  2004influential reference
• Protein digestibility and relevance to allergenicity.

  2003cited by this paper
• Genetic modification: The production of recombinant pharmaceutical proteins in plants

  2003cited by this paper
• Localization of a bacterial protein in starch granules of transgenic maize kernels

  2003influential reference
• Starlink corn: a risk analysis.

  2002cited by this paper
• Preclinical safety evaluation of biotechnology-derived pharmaceuticals

  2002cited by this paper
• Expression of a synthetic E. coli heat-labile enterotoxin B sub-unit (LT-B) in maize

  2002cited by this paper
• Delivery of subunit vaccines in maize seed

  2002cited by this paper
• Escherichia coli Heat-Labile Enterotoxin B Subunit Is a More Potent Mucosal Adjuvant than Its Closely Related Homologue, the B Subunit of Cholera Toxin

  2001cited by this paper
• N-glycosylation potential of maize: The human lactoferrin used as a model

  2001cited by this paper
• Immune modulation by the cholera-like enterotoxin B-subunits: from adjuvant to immunotherapeutic.

  2000cited by this paper
• Agricultural biotechnology and societal decision-making: the role of risk analysis

  2000cited by this paper
• Combining Uncertainty Factors in Deriving Human Exposure Levels of Noncarcinogenic Toxicants

  1999cited by this paper
• The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT).

  1999cited by this paper
• Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato

  1998cited by this paper
• The use of amino acid sequence alignments to assess potential allergenicity of proteins used in genetically modified foods.

  1998cited by this paper
• Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin

  1997influential reference
• 5 – Use of Escherichia coli Heat-Labile Enterotoxin as an Oral Adjuvant

  1996cited by this paper
• Continuing survey of food intakes by individuals

  1985cited by this paper
• In vitro formation of hybrid toxins between subunits of Escherichia coli heat-labile enterotoxin and those of cholera enterotoxin

  1981cited by this paper
• On Risk and Plant-based Biopharmaceuticals

  year unknowncited by this paper

• High-value products from transgenic maize.

  2011cites this paper
• Advancing environmental risk assessment for transgenic biofeedstock crops

  2009cites this paper
• Persistence and degradation of maize-expressed vaccine protein, Escherichia coli heat-labile enterotoxin subunit B, in soil and water.

  2008cites this paper
• Maize plants: An ideal production platform for effective and safe molecular pharming

  2008cites this paper
• Subacute effects of maize-expressed vaccine protein, Escherichia coli heat-labile enterotoxin subunit B (LTB), on the Springtail, Folsomia candida , and the earthworm, Eisenia fetida.

  2008cites this paper
• Assessing Risks of Plant-Based Pharmaceuticals: I. Human Dietary Exposure

  2008cites this paper
• Environmental Chemistry PERSISTENCE AND DEGRADATION OF MAIZE-EXPRESSED VACCINE PROTEIN, ESCHERICHIA COLI HEAT-LABILE ENTEROTOXIN SUBUNIT B, IN SOIL AND WATER

  2008cites this paper
• Molecular pharming in cereal crops

  2008cites this paper
• Evaluation of low dose exposure and immunogenicity of transgenic maize expressing the Escherichia coli heat-labile toxin B subunit when fed intermittently and daily

  2007cites this paper
• Environmental studies on the fate and effects of pharma proteins produced in transgenic maize

  2007cites this paper
• RISK ASSESSMENT OF PLANT-BASED PHARMACEUTICALS AND BIOLOGICS

  2006influential citation
• Low-Dose Exposure and Immunogenicity of Transgenic Maize Expressing the Escherichia coli Heat-Labile Toxin B Subunit

  2006cites this paper